PICTET ASSET MANAGEMENT SA - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 154 filers reported holding XENON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.4%.

Quarter-by-quarter ownership
PICTET ASSET MANAGEMENT SA ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$78,260,105
+9.1%
2,032,730
+1.4%
0.09%
+3.3%
Q1 2023$71,733,790
+85729.6%
2,004,297
-5.4%
0.09%
-25.6%
Q4 2022$83,577
-99.9%
2,119,619
-7.3%
0.12%
-1.6%
Q3 2022$82,574,000
+49.2%
2,287,365
+25.7%
0.12%
+59.7%
Q2 2022$55,348,000
+36.6%
1,819,476
+37.3%
0.08%
+67.4%
Q1 2022$40,515,0001,325,3260.05%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 266,961$9,119,38810.70%
COMMODORE CAPITAL LP 1,845,000$63,025,2007.37%
TLS Advisors LLC 32,956$1,1264.56%
Altium Capital Management LP 228,000$7,788,4804.06%
Paradigm Biocapital Advisors LP 1,491,835$50,961,0843.46%
GREAT POINT PARTNERS LLC 500,001$17,080,0343.11%
DAFNA Capital Management LLC 280,538$9,583,1782.98%
Nan Fung Group Holdings Ltd 106,680$3,644,1892.95%
Affinity Asset Advisors, LLC 300,438$10,262,9622.89%
Avoro Capital Advisors LLC 4,900,000$167,384,0002.61%
View complete list of XENON PHARMACEUTICALS INC shareholders